Literature DB >> 2156003

Biochemical and immunological characterization of the major structural proteins of feline immunodeficiency virus.

R Steinman1, J Dombrowski, T O'Connor, R C Montelaro, Q Tonelli, K Lawrence, C Seymour, J Goodness, N C Pedersen, P R Andersen.   

Abstract

Feline immunodeficiency virus (FIV) structural proteins were identified using sera obtained from experimentally inoculated cats. Proteins analysed by both radioimmunoprecipitation and Western blotting were specific for FIV infection and failed to cross-react with either antisera to feline leukaemia virus of feline syncytium-forming virus. Western blot analysis of purified virus revealed immunoreactive proteins with apparent Mr of 65K, 50K, 40K, 32K, 24K, 15K and 10K. The major core structural proteins of the virus were isolated by reverse phase HPLC and the aminoterminal sequences of p10 and p24 were determined. Monoclonal antibodies specific for p24 suggested the presence of a precursor protein that could be detected in 35[S]methionine/cysteine-labelled, virus-infected cell extracts. This putative precursor protein possessed an apparent Mr of 50K (Pr50gag). Further analysis revealed the presence of two additional proteins of 130K and 40K. Experiments utilizing tunicamycin, endoglycosidase H and glycopeptidase F revealed that p130 and p40 exhibited properties characteristic of glycoproteins. Our studies also indicated that FIV is immunologically related to other lentiviruses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156003     DOI: 10.1099/0022-1317-71-3-701

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Expression of feline immunodeficiency virus gag and env precursor proteins in Spodoptera frugiperda cells and their use in immunodiagnosis.

Authors:  E J Verschoor; A L van Vliet; H F Egberink; W Hesselink; M C Horzinek; A de Ronde
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

Review 2.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Processing of the glycoprotein of feline immunodeficiency virus: effect of inhibitors of glycosylation.

Authors:  E B Stephens; E Monck; K Reppas; E J Butfiloski
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

4.  A western blot assay for the detection of antibodies to bovine immunodeficiency-like virus in experimentally inoculated cattle, sheep, and goats.

Authors:  C A Whetstone; M J VanDerMaaten; J M Miller
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

5.  Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate.

Authors:  T Miyazawa; M Fukasawa; A Hasegawa; N Maki; K Ikuta; E Takahashi; M Hayami; T Mikami
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  Plasma viral RNA load predicts disease progression in accelerated feline immunodeficiency virus infection.

Authors:  L J Diehl; C K Mathiason-Dubard; L L O'Neil; E A Hoover
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 7.  Reflections on viruses and cancer.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

Review 8.  The genome of feline immunodeficiency virus.

Authors:  T Miyazawa; K Tomonaga; Y Kawaguchi; T Mikami
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus.

Authors:  J H Elder; M Schnölzer; C S Hasselkus-Light; M Henson; D A Lerner; T R Phillips; P C Wagaman; S B Kent
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

10.  Expression of feline immunodeficiency virus gag gene in Escherichia coli.

Authors:  T Furuya; A Hasegawa; M Saitoh; T Miyazawa; Y Tohya; M Hayami; E Takahashi; K Miki; T Mikami
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.